Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

IGNY

Ignyte Acquisition (IGNY)

Ignyte Acquisition Corporation
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:IGNY
DataHoraFonteTítuloCódigoCompanhia
27/06/202318:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IGNYIgnyte Acquisition Corporation
27/06/202317:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IGNYIgnyte Acquisition Corporation
22/05/202317:32Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:IGNYIgnyte Acquisition Corporation
31/03/202317:22Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)NASDAQ:IGNYIgnyte Acquisition Corporation
02/03/202308:31Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:IGNYIgnyte Acquisition Corporation
02/03/202308:29Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:IGNYIgnyte Acquisition Corporation
28/02/202318:02Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:IGNYIgnyte Acquisition Corporation
28/02/202310:32Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:IGNYIgnyte Acquisition Corporation
14/02/202318:55Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:IGNYIgnyte Acquisition Corporation
14/02/202317:39Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:IGNYIgnyte Acquisition Corporation
15/12/202208:34Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:IGNYIgnyte Acquisition Corporation
21/11/202219:27Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:IGNYIgnyte Acquisition Corporation
01/11/202217:29Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:IGNYIgnyte Acquisition Corporation
27/10/202209:05Business WireIgnyte Acquisition Corp. Stockholders Approve Proposed Business Combination with Peak BioNASDAQ:IGNYIgnyte Acquisition Corporation
19/10/202207:03Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:IGNYIgnyte Acquisition Corporation
18/10/202213:17Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:IGNYIgnyte Acquisition Corporation
17/10/202218:18Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)NASDAQ:IGNYIgnyte Acquisition Corporation
07/10/202207:03Edgar (US Regulatory)Proxy Statement - Merger or Acquisition (definitive) (defm14a)NASDAQ:IGNYIgnyte Acquisition Corporation
23/09/202218:01Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:IGNYIgnyte Acquisition Corporation
17/05/202218:04Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:IGNYIgnyte Acquisition Corporation
28/04/202217:32Business WirePeak Bio and Ignyte Acquisition Corp. Announce Business Combination Agreement to Create Publicly Listed Oncology and Inflammation CompanyNASDAQ:IGNYIgnyte Acquisition Corporation
01/06/202115:11Business WireIgnyte Acquisition Corp. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on For...NASDAQ:IGNYIgnyte Acquisition Corporation
19/04/202112:44Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:IGNYIgnyte Acquisition Corporation
15/04/202117:44Edgar (US Regulatory)Annual Report (10-k)NASDAQ:IGNYIgnyte Acquisition Corporation
 Apresentando as notícias mais relevantes sobre:NASDAQ:IGNY

Seu Histórico Recente